| The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis K Riazi, H Azhari, JH Charette, FE Underwood, JA King, EE Afshar, ... The lancet gastroenterology & hepatology 7 (9), 851-861, 2022 | 782 | 2022 |
| Embolization of portosystemic shunts for treatment of medically refractory hepatic encephalopathy AM Lynn, S Singh, SE Congly, D Khemani, DH Johnson, RH Wiesner, ... Liver Transplantation 22 (6), 723-731, 2016 | 69 | 2016 |
| Immunotargeting with CD154 (CD40 ligand) enhances DNA vaccine responses in ducks SL Gares, KP Fischer, SE Congly, S Lacoste, WR Addison, DL Tyrrell, ... Clinical and vaccine immunology 13 (8), 958-965, 2006 | 59 | 2006 |
| Nationwide estimates and risk factors of hospital readmission in patients with cirrhosis in the United States AA Shaheen, HH Nguyen, SE Congly, GG Kaplan, MG Swain Liver International 39 (5), 878-884, 2019 | 55 | 2019 |
| Tenofovir disoproxil fumarate significantly decreases serum lipoprotein levels compared with entecavir nucleos (t) ide analogue therapy in chronic hepatitis B carriers AA Shaheen, M AlMattooq, S Yazdanfar, KW Burak, MG Swain, ... Alimentary Pharmacology & Therapeutics 46 (6), 599-604, 2017 | 54 | 2017 |
| Epidemiologic burden and treatment of chronic symptomatic functional bowel disorders in the United States: a nationwide analysis C Ma, SE Congly, KL Novak, PJ Belletrutti, M Raman, M Woo, ... Gastroenterology 160 (1), 88-98. e4, 2021 | 50 | 2021 |
| Portal vein thrombosis: should anticoagulation be used? SE Congly, SS Lee Current gastroenterology reports 15, 1-7, 2013 | 47 | 2013 |
| Sexual dysfunction and sex hormone abnormalities in patients with cirrhosis: Review of pathogenesis and management SF Neong, EO Billington, SE Congly Hepatology, 2018 | 44 | 2018 |
| Sofosbuvir-based antiviral therapy is highly effective in recurrent hepatitis C in liver transplant recipients: Canadian multicenter “real-life” experience N Faisal, M Bilodeau, B Aljudaibi, G Hirsch, EM Yoshida, T Hussaini, ... Transplantation 100 (5), 1059-1065, 2016 | 43 | 2016 |
| Amoebic liver abscess in USA: a population‐based study of incidence, temporal trends and mortality SE Congly, AAM Shaheen, L Meddings, GG Kaplan, RP Myers Liver International 31 (8), 1191-1198, 2011 | 38 | 2011 |
| Impact of the COVID-19 pandemic on hospitalizations for alcoholic hepatitis or cirrhosis in Alberta, Canada AA Shaheen, K Kong, C Ma, C Doktorchik, CS Coffin, MG Swain, ... Clinical Gastroenterology and Hepatology 20 (5), e1170-e1179, 2022 | 35 | 2022 |
| Characterization of hepatitis B virus genotypes and quantitative hepatitis B surface antigen titres in North American tertiary referral liver centres SE Congly, P Wong, SA Al‐Busafi, K Doucette, SK Fung, P Ghali, ... Liver International 33 (9), 1363-1369, 2013 | 28 | 2013 |
| Treatment of moderate to severe respiratory COVID-19: a cost-utility analysis SE Congly, RA Varughese, CE Brown, FM Clement, L Saxinger Scientific Reports 11 (1), 17787, 2021 | 26 | 2021 |
| Epidemiologic and clinical features of chronic hepatitis B virus infection in 8 Canadian provinces: a descriptive study by the Canadian HBV Network CS Coffin, A Ramji, CL Cooper, D Miles, KE Doucette, P Wong, E Tam, ... Canadian Medical Association Open Access Journal 7 (4), E610-E617, 2019 | 25 | 2019 |
| Cost‐effectiveness of quantitative hepatitis B virus surface antigen testing in pregnancy in predicting vertical transmission risk G Samadi Kochaksaraei, SE Congly, T Matwiy, E Castillo, SR Martin, ... Liver International 36 (11), 1604-1610, 2016 | 25 | 2016 |
| Race and ethnicity in non-alcoholic fatty liver disease (NAFLD): a narrative review K Riazi, MG Swain, SE Congly, GG Kaplan, AA Shaheen Nutrients 14 (21), 4556, 2022 | 22 | 2022 |
| Trends in the economic burden of chronic liver diseases and cirrhosis in the United States: 1996–2016 C Ma, AS Qian, NH Nguyen, I Stukalin, SE Congly, AA Shaheen, ... Official journal of the American College of Gastroenterology| ACG 116 (10 …, 2021 | 22 | 2021 |
| The cirrhosis care Alberta (CCAB) protocol: implementing an evidence-based best practice order set for the management of liver cirrhosis-a hybrid type I effectiveness … M Carbonneau, EA Eboreime, A Hyde, D Campbell-Scherer, P Faris, ... BMC health services research 20, 1-13, 2020 | 21 | 2020 |
| Interpreting reported risks associated with use of proton pump inhibitors: residual confounding in a 10-year analysis of national ambulatory data C Ma, AA Shaheen, SE Congly, CN Andrews, P Moayyedi, N Forbes Gastroenterology 158 (3), 780-782. e3, 2020 | 21 | 2020 |
| Cost effectiveness of early insertion of transjugular intrahepatic portosystemic shunts for recurrent ascites NT Shen, Y Schneider, SE Congly, RE Rosenblatt, Y Namn, BE Fortune, ... Clinical Gastroenterology and Hepatology 16 (9), 1503-1510. e3, 2018 | 21 | 2018 |
Abdel Aziz ShaheenUniversity of CalgaryVerified email at ucalgary.ca
